Companies

Tarsus Pharmaceuticals, Inc. (TARS) SEC filings

CIK 0001819790 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)451.4 M25.8 M
Net income (USD)-62.1 M-13.8 M-26.8 M
Diluted EPS (USD/shares)-1.59-2.52

Latest filings

FiledFormDescriptionPeriod
2026-10-13S-3ASRS-3ASR
2026-10-13S-3ASRS-3ASR
2026-10-138-K/A8-K/A items 9.012026-09-04
2026-09-174FORM 42026-09-15
2026-09-174FORM 42026-09-15
2026-09-174FORM 42026-09-15
2026-09-15144144
2026-09-108-K8-K items 2.01,8.01,9.012026-09-04
2026-09-094FORM 42026-09-04
2026-09-094FORM 42026-09-04
2026-09-094FORM 42026-09-04
2026-09-04144144
2026-09-04144144
2026-09-04144144
2026-09-04144144
2026-09-034FORM 42026-09-02
2026-09-034FORM 42026-09-01
2026-09-02144144
2026-09-02144144
2026-09-02144144
2026-09-02144144
2026-09-01144144
2026-09-01144144
2026-08-25144144
2026-08-19144144

Forms on file (last 1,000): 4 303, 144 118, 8-K 70, SC 13G/A 28, 3 24, SC 13G 19, 10-Q 18, SCHEDULE 13G/A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=TARS (0.002 USD), /gw/filings/filings?ticker=TARS&form=8-K, /gw/filings/facts?ticker=TARS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange